V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Row
A
ALLOAI Stock Diagnostic Report

Allogene Therapeutics CFO Geoffrey Parker sells $48,698 in stock

ALLO's CFO sold approximately $48,698 worth of company stock, but due to the small amount, the impact on the stock price is limited and the direction is considered neutral.

View Source Article ↗
AI CATALYST SCORE30 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

ALLO Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-10-24 05:57:34ALLO30RowView Report →
2026-09-02 12:49:43ALLO50RowView Report →
2026-08-12 23:40:47ALLO80MidView Report →
View Full History for ALLO (Blueprint) →